National Prospective Study of Children Under 18 With Idiopathic Nephrotic Syndrome in France
Led by University Hospital, Limoges · Updated on 2026-03-13
1180
Participants Needed
48
Research Sites
939 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective, multicenter cohort study to follow children with idiopathic nephrotic syndrome INS, a rare kidney disease. The study aims to collect data on pediatric patients treated by pediatric nephrologists in France and its overseas territories to better understand the diseases characteristics and support future clinical trials.
The study involves regularly recording medical, biological, psychological, and social data through routine clinical follow-ups, hospitalizations, and consultations. Additionally, annual telephone interviews will be conducted for patients in remission. Quality of life, treatment adherence, and treatment impact questionnaires will also be collected. A biobank is established to collect blood, urine, hair, and nail samples at the disease onset before immunosuppressive treatment begins.
Participants will be followed from disease onset until age 18 or transfer to adult nephrology care. Data is collected via a secure website, medically validated and entered by clinical research staff. The main outcome is the number of cases included and their characteristics over two years. Participation involves routine care visits, interviews, and questionnaires, with continued monitoring planned through the study period ending in 2048.
CONDITIONS
Brief Title
A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
Research Team
V
Vincent Guigonis, MD
C
Claire Bahans, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with idiopathic nephrotic syndrome after January 1, 2018
Seen at least once by a pediatrician who is a member of the Society of Pediatric Nephrology
Residing in France or its overseas territories
Consent signed by parents and patient's agreement to participate (if of age)
Affiliated to a social security system
You will not qualify if you...
Refusal of the patient or legal representatives to participate in the cohort
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surveillance
Duration - Up to 18 years or until transfer to adult nephrology care
Participants with idiopathic nephrotic syndrome are regularly observed through medical record data collected during routine clinical follow-up, telephone interviews for annual follow-ups, and completion of quality of life, treatment compliance, and aesthetic impact questionnaires.
Regular routine clinical visits and annual telephone interviews
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
National Prospective Study of Children Under 18 With Idiopathic Nephrotic Syndrome in France
The German FOrMe Registry for Children and Adults with Idiopathic Nephrotic Syndrome,
Focal Segmental Glomerulosclerosis, and Minimal Change Disease
Collecting clinical data and biosamples for research
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
A "Trial within a Cohort" platform for pediatric clinical trials on idiopathic nephrotic syndrome: scope, objectives, and design of the retrospective-prospective cohort PIN'SNP.